How can you determine if a patient has acute liver failure?

How to Determine if a Patient Has Acute Liver Failure

Acute liver failure (ALF) is diagnosed by the presence of rapidly progressive liver dysfunction with coagulopathy (PT ratio <50% or INR ≥1.5) and hepatic encephalopathy occurring within 26 weeks in a patient without preexisting liver disease. 1

Core Diagnostic Criteria

The diagnosis requires all three of the following elements:

• Rapidly progressive liver dysfunction developing in less than 26 weeks 1
• Coagulopathy: Prothrombin time (PT) ratio less than 50% or INR ≥1.5-2.5 1
• Hepatic encephalopathy of any grade 1
• No preexisting liver disease (this distinguishes ALF from acute-on-chronic liver failure) 1

Severity Classification

Severe ALF is defined by PT ratio <50% alone, while serious ALF requires both PT ratio <50% AND encephalopathy 1. The time from jaundice onset to encephalopathy development further classifies the syndrome: fulminant hepatitis occurs when encephalopathy develops within 15 days of jaundice onset 1.

Essential Initial Investigations

When ALF is suspected, immediately obtain the following blood tests 1:

• PT/INR and Factor V levels to assess coagulation 1
• Serum acetaminophen level (most common cause in developed countries) 1
• Hepatitis serology: IgM anti-HAV, HBsAg, and anti-HBc IgM 1
• Urine toxicology screen for amphetamine and cocaine 1
• Blood glucose (monitor at least every 2 hours due to hypoglycemia risk) 1
• Arterial blood gas and lactate level 1
• Arterial ammonia 1
• Liver transaminases (ALT/AST) - note that modest elevations (typically <2000 IU/L) may occur despite severe disease 1

Imaging and Additional Studies

Perform the following to assess severity and identify specific etiologies 1:

• Hepatic Doppler ultrasound to evaluate vascular patency and liver architecture 1
• Echocardiography to assess cardiac function and hemodynamic status 1
• Autoantibody testing (ANA, ASMA) if autoimmune hepatitis is suspected 1

Clinical Assessment of Encephalopathy

Encephalopathy should be monitored frequently using the Glasgow Coma Scale 1. Progressive hepatic encephalopathy (Glasgow <8) requires tracheal intubation and sedation 1. The presence and grade of encephalopathy is critical for both diagnosis and prognosis.

Key Distinguishing Features from Other Conditions

Distinguishing ALF from Acute-on-Chronic Liver Failure (ACLF)

ACLF occurs in patients with preexisting chronic liver disease or cirrhosis and involves acute hepatic decompensation with extrahepatic organ failure 1. In contrast, ALF occurs in patients without known liver disease 1. ACLF requires: (1) acute onset with rapid deterioration, (2) elevated bilirubin and INR in patients with chronic liver disease, and (3) at least one extrahepatic organ failure 1.

Special Diagnostic Patterns

Wilson disease presenting as ALF has characteristic findings 1:

• Coombs-negative hemolytic anemia with acute intravascular hemolysis
• Modest aminotransferase elevations (typically <2000 IU/L)
• Markedly subnormal alkaline phosphatase (typically <40 IU/L)
• Alkaline phosphatase to total bilirubin ratio <2
• Serum copper typically ≥200 μg/dL
• Female predominance (2:1 ratio)

Autoimmune hepatitis as ALF may present with 1:

• Positive autoantibodies (ANA, ASMA) in 93% of cases
• Atypical liver histology showing lobular hepatitis and centrilobular necrosis
• Autoantibodies may be initially absent but develop later

Common Pitfalls to Avoid

• Do not underestimate disease severity based on modest aminotransferase elevations alone—coagulopathy and encephalopathy are the critical markers 1
• Do not delay acetaminophen level testing even if history is unclear, as it is the most common cause and has specific treatment 1
• Do not wait for "chronicity" demonstration in acute presentations before diagnosing and treating—ALF evolves rapidly 1
• Do not assume absence of preexisting liver disease without proper history and imaging, as this fundamentally changes the diagnosis to ACLF 1

Immediate Actions Upon Diagnosis

Once ALF is confirmed 1:

• Contact transplant center early regardless of initial severity
• Administer N-acetylcysteine systematically regardless of suspected etiology
• Start acyclovir if herpes simplex virus hepatitis is suspected (especially if fever present)
• Maintain serum sodium between 140-145 mmol/L
• Avoid nephrotoxic drugs including NSAIDs
• Do not routinely correct coagulation unless active bleeding occurs